Functional oligosaccharides refer to oligosaccharides that are difficult or impossible to be digested and absorbed by the human body and have special physiological effects on the human body. Its sweetness is generally only 30-50% of that of sucrose, and it has physiological functions such as low-calorie, anti-caries, prevention and treatment of diabetes, and improvement of intestinal colony structure. Due to the special physiological functions of functional oligosaccharides, it becomes a nutrient and health care product. A new generation of food-effect raw materials that integrate diet and therapy. It is a new functional sugar source that replaces sucrose and has a wide range of uses and application prospects. Common functional oligosaccharides include: xylo-oligosaccharides, fructooligosaccharides, galacto-oligosaccharides, isomaltose, raffinose and so on. XOS, GOS, FOS, IMO, Raffinose, oligosaccharide Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualynbios.com
Science and Technology Daily reported on July 1, 2005: According to the Canadian News Agency, at the world’s largest biotechnology conference in Philadelphia recently, Canadian Minister of International Trade Peterson said that only by working closely with other countries can Canada’s new drugs be accelerated. Progress in the development of other new products. He said that due to the complexity of biotechnology, long research period, high cost, and high risk, no country can succeed alone. Biotechnology has no national borders. To make new discoveries, international cooperation must be carried out immediately. International cooperation is the key to the future development of biological sciences. Peterson said that Canada will implement a five-year, 20-million-dollar international scientific and technological cooperation research and development program in key areas, including China, Brazil, India, and Israel. The plan covers areas such as medicine, environment, and energy. It is planned to start this fall. It mainly supports cooperative projects that have a major impact on economic development. Funding targets include companies and universities. Although the number of Canadian biotech companies ranks second in the world, they still hope to attract more investment. The federal government expects that by 2007, Canada’s investment in biotechnology-related research will reach US$11 billion. Canadian biotechnology companies are engaged in research and development of technologies related to agriculture. Other areas include biological anti-terrorism, medical equipment, drugs, clinical trials, and stem cell research.